Amedeo Smart

Free Medical Literature Service


 

Amedeo

Chronic Heart Failure

  Free Subscription

16.08.2021

1 Cardiol Clin
1 Cardiovasc Res
1 Circ Heart Fail
1 Circulation
1 Eur Heart J
21 Eur J Heart Fail
2 Int J Cardiol
5 J Am Coll Cardiol
12 J Card Fail
1 J Mol Cell Cardiol



    Cardiol Clin

  1. LEWEY J, Andrade L, Levine LD
    Valvular Heart Disease in Pregnancy.
    Cardiol Clin. 2021;39:151-161.
    >> Share


    Cardiovasc Res

  2. RICHARDS AM
    Proteomic probing for markers and mechanisms in Heart Failure.
    Cardiovasc Res. 2021 Aug 10. pii: 6347578. doi: 10.1093.
    >> Share


    Circ Heart Fail

  3. RIVERA AS, Sinha A, Ahmad FS, Thorp E, et al
    Long-Term Trajectories of Left Ventricular Ejection Fraction in Patients With Chronic Inflammatory Diseases and Heart Failure: An Analysis of Electronic Health Records.
    Circ Heart Fail. 2021 Aug 10:CIRCHEARTFAILURE121008478.
    >> Share


    Circulation

  4. KORF-KLINGEBIEL M, Reboll MR, Polten F, Weber N, et al
    Myeloid-Derived Growth Factor Protects Against Pressure Overload-Induced Heart Failure by Preserving Sarco/Endoplasmic Reticulum Ca(2+)-ATPase Expression in Cardiomyocytes.
    Circulation. 2021 Aug 10. doi: 10.1161/CIRCULATIONAHA.120.053365.
    >> Share


    Eur Heart J

  5. FEDCHENKO M, Mandalenakis Z, Giang KW, Rosengren A, et al
    Long-term outcomes after myocardial infarction in middle-aged and older patients with congenital heart disease-a nationwide study.
    Eur Heart J. 2020 Nov 21. pii: 5997447. doi: 10.1093.
    >> Share


    Eur J Heart Fail

  6. FERREIRA JP
    Circulating levels of procollagen type I carboxy-terminal propeptide reflect myocardial fibrosis.
    Eur J Heart Fail. 2021;23:945-946.
    >> Share

  7. KUSCHYK J, Falk P, Demming T, Marx O, et al
    Long-term clinical experience with cardiac contractility modulation therapy delivered by the Optimizer Smart system.
    Eur J Heart Fail. 2021;23:1160-1169.
    >> Share

  8. MEHRA MR, Crandall DL, Gustafsson F, Jorde UP, et al
    Aspirin and left ventricular assist devices: rationale and design for the international randomized, placebo-controlled, non-inferiority ARIES HM3 trial.
    Eur J Heart Fail. 2021;23:1226-1237.
    >> Share

  9. SEGAR MW, Pandey A
    Omics, machine learning, and personalized medicine in heart failure with preserved ejection fraction: promising future or false hope?
    Eur J Heart Fail. 2021;23:992-994.
    >> Share

  10. PELLICORI P, Fitchett D, Kosiborod MN, Ofstad AP, et al
    Use of diuretics and outcomes in patients with type 2 diabetes: findings from the EMPA-REG OUTCOME trial.
    Eur J Heart Fail. 2021;23:1085-1093.
    >> Share

  11. AMMIRATI E, Varrenti M, Veronese G, Fanti D, et al
    Prevalence and outcome of patients with acute myocarditis and positive viral search on nasopharyngeal swab.
    Eur J Heart Fail. 2021;23:1242-1245.
    >> Share

  12. TURNER JM, Cox ZL, Testani JM
    Improving renal function during diuresis: useful information or just noise?
    Eur J Heart Fail. 2021;23:1131-1133.
    >> Share

  13. TOMASONI D, Adamo M, Metra M
    June 2021 at a glance: focus on epidemiology, biomarkers and medical treatment.
    Eur J Heart Fail. 2021;23:847-849.
    >> Share

  14. TOMASONI D, Adamo M, Metra M
    July 2021 at a glance: focus on blood volume distribution, haemodynamics and adherence to therapy.
    Eur J Heart Fail. 2021;23:1059-1061.
    >> Share

  15. DENIAU B, Picod A, Azibani F, Gayat E, et al
    The CLIP-based mortality score in cardiogenic shock: suitable only for cardiogenic shock?
    Eur J Heart Fail. 2021;23:1240-1242.
    >> Share

  16. RAAFS AG, Verdonschot JAJ, Henkens MTHM, Adriaans BP, et al
    The combination of carboxy-terminal propeptide of procollagen type I blood levels and late gadolinium enhancement at cardiac magnetic resonance provides additional prognostic information in idiopathic dilated cardiomyopathy - A multilevel assessment o
    Eur J Heart Fail. 2021;23:933-944.
    >> Share

  17. KARAMICHALAKIS N, Ikonomidis I, Parissis J, Simitsis P, et al
    Association of ventricular-arterial interaction with the response to cardiac resynchronization therapy.
    Eur J Heart Fail. 2021;23:1238-1240.
    >> Share

  18. DAMY T, Sultan MB, Witteles R
    Reply to the letter regarding the article 'Efficacy and safety of tafamidis doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and long-term extension study'.
    Eur J Heart Fail. 2021;23:1057-1058.
    >> Share

  19. FINOCCHIARO G, Sinagra G, Papadakis M, Carr-White G, et al
    The labyrinth of nomenclature in Cardiology. Eternal dilemmas and new challenges on the horizon in the personalized medicine era.
    Eur J Heart Fail. 2021;23:1062-1067.
    >> Share

  20. GREENBERG B, Adler E, Campagnari C, Yagil A, et al
    A machine learning risk score predicts mortality across the spectrum of left ventricular ejection fraction.
    Eur J Heart Fail. 2021;23:995-999.
    >> Share

  21. PARCHA V, Arora P
    Sodium-glucose co-transporter 2 inhibitors: strength of evidence for a cardio-renal-metabolic therapy.
    Eur J Heart Fail. 2021;23:1009-1011.
    >> Share

  22. SATTAR N, Januzzi JL
    Can biomarkers help find the 'sweet spot' for treating patients with diabetes?
    Eur J Heart Fail. 2021;23:1037-1039.
    >> Share

  23. ZYMLINSKI R, Biegus J, Ponikowski P
    Not all fluid overloads are the same: some practical considerations for better decongestion.
    Eur J Heart Fail. 2021;23:1106-1109.
    >> Share

  24. HAVERKAMP W, Butler J, Anker SD
    Can we trust a smartwatch ECG? Potential and limitations.
    Eur J Heart Fail. 2021;23:850-853.
    >> Share

  25. GARCIA-PAVIA P, Bengel F, Brito D, Damy T, et al
    Expert consensus on the monitoring of transthyretin amyloid cardiomyopathy.
    Eur J Heart Fail. 2021;23:895-905.
    >> Share

  26. STEWART COATS A
    Figures of the Heart Failure Association: Professor Dr. Wilfried Mullens, Board Member, 2018-2022, Coordinator of Study Group of Cardiorenal Dysfunction and Co-coordinator of Committee on Cardiac Devices.
    Eur J Heart Fail. 2021 Aug 9. doi: 10.1002/ejhf.2325.
    >> Share


    Int J Cardiol

  27. TADA A, Nagai T, Omote K, Iwano H, et al
    Performance of the H2FPEF and the HFA-PEFF scores for the diagnosis of heart failure with preserved ejection fraction in Japanese patients: A report from the Japanese multicenter registry.
    Int J Cardiol. 2021 Aug 5. pii: S0167-5273(21)01211.
    >> Share

  28. VINTER N, Frost L, Benjamin EJ
    Heart failure and atrial fibrillation - does heart failure subtype matter?
    Int J Cardiol. 2021 Aug 6. pii: S0167-5273(21)01216.
    >> Share


    J Am Coll Cardiol

  29. SELVARAJ S, Claggett B, Minamisawa M, Windham BG, et al
    Atrial Fibrillation and Ischemic Stroke with the Amyloidogenic V122I Transthyretin Variant among Black Americans.
    J Am Coll Cardiol. 2021 Apr 19. pii: S0735-1097(21)04808.
    >> Share

  30. EIKELBOOM JW, Bhatt DL, Fox KAA, Bosch J, et al
    Mortality Benefit of Rivaroxaban Plus Aspirin in Patients With Chronic Coronary or Peripheral Artery Disease.
    J Am Coll Cardiol. 2021;78:14-23.
    >> Share

  31. MEWTON N, Baudry G, Sebbag L
    Pneumonia in Chronic Heart Failure: What About a Full Picture of the Puzzle?
    J Am Coll Cardiol. 2021;78:759.
    >> Share

  32. SHEN L, Jhund PS, McMurray JJV
    Reply: Pneumonia and the Bigger Picture of Infection in Heart Failure.
    J Am Coll Cardiol. 2021;78:760-761.
    >> Share

  33. DROZD M, Cubbon RM
    Infection and Adverse Outcomes in People With Chronic Heart Failure: Highlighting a Neglected Problem.
    J Am Coll Cardiol. 2021;78:760.
    >> Share


    J Card Fail

  34. LALA A, Mentz RJ
    Language Matters: Understanding Barriers to Medication Adherence to Better Tailor Heart Failure Care.
    J Card Fail. 2021;27:825.
    >> Share

  35. ALBER NM
    Innovations in Heart Failure Wanted.
    J Card Fail. 2021;27:920-921.
    >> Share

  36. YANG E, Spragg D, Schulman S, Gilotra NA, et al
    Rate Versus Rhythm Control in Heart Failure Patients with Post-Operative Atrial Fibrillation After Cardiac Surgery.
    J Card Fail. 2021;27:915-919.
    >> Share

  37. POLNAK JF
    Leaning in to the Hard Conversations: A Case Example of the Interplay of Race and Heart Failure Management.
    J Card Fail. 2021;27:913-914.
    >> Share

  38. VARSHNEY AS, Bhatt AS, Vaduganathan M
    Hospitalization of Patients With (But Not for) Heart Failure: An Opportunity for Accelerated Guideline-Directed Medical Therapy Optimization?
    J Card Fail. 2021;27:910-912.
    >> Share

  39. TRIPOSKIADIS F, Xanthopoulos A, Starling RC
    Medical Treatment of Heart Failure: Ignore the Ejection Fraction and Treat All?
    J Card Fail. 2021;27:907-909.
    >> Share

  40. BEREI T, Forsyth P, Balakumaran K, Harshaw-Ellis K, et al
    Implementing Nonphysician Provider Guideline-Directed Medical Therapy Heart Failure Clinics: A Multi-National Imperative.
    J Card Fail. 2021;27:896-906.
    >> Share

  41. DUNBAR SB, Tan X, Lautsch D, Yang M, et al
    Patient-centered Outcomes in HFrEF Following a Worsening Heart Failure Event: A Survey Analysis.
    J Card Fail. 2021;27:877-887.
    >> Share

  42. ZHANG J, Shantsila E, Lip GYH
    Heart Failure With Sinus Rhythm: Does Anticoagulation Reduce Stroke at All?
    J Card Fail. 2021;27:865-868.
    >> Share

  43. WU JR, Moser DK
    Health-Related Quality of Life Is a Mediator of the Relationship Between Medication Adherence and Cardiac Event-Free Survival in Patients with Heart Failure.
    J Card Fail. 2021;27:848-856.
    >> Share

  44. CARNICELLI AP, Lippmann SJ, Greene SJ, Mentz RJ, et al
    Sacubitril/Valsartan Initiation and Postdischarge Adherence Among Patients Hospitalized for Heart Failure.
    J Card Fail. 2021;27:826-836.
    >> Share

  45. SAVARESE G, Uijl A, Lund LH, Anker SD, et al
    Empagliflozin in Heart Failure With Predicted Preserved Versus Reduced Ejection Fraction: Data From the EMPA-REG OUTCOME Trial.
    J Card Fail. 2021;27:888-895.
    >> Share


    J Mol Cell Cardiol

  46. AKSENTIJEVIC D, Shattock MJ
    With a grain of salt: Sodium elevation and metabolic remodelling in heart failure.
    J Mol Cell Cardiol. 2021 Aug 6. pii: S0022-2828(21)00156.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016